Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$786M |
| 2 |
Apple
AAPL
|
+$564M |
| 3 |
Amazon
AMZN
|
+$486M |
| 4 |
Meta Platforms (Facebook)
META
|
+$331M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sherwin-Williams
SHW
|
+$1.88B |
| 2 |
Alibaba
BABA
|
+$1.21B |
| 3 |
Home Depot
HD
|
+$320M |
| 4 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$274M |
| 5 |
FLIR
FLIR Systems, Inc. (DE) Common Stock
FLIR
|
+$135M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.98% |
| 2 | Financials | 13.87% |
| 3 | Healthcare | 13.39% |
| 4 | Consumer Discretionary | 11.81% |
| 5 | Communication Services | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3676
Aptevo Therapeutics
APVO
$5.12M
| – | – |
0
| – | – |
|
3677
SB Financial Group
SBFG
$164M
| $872K | ﹤0.01% |
49,526
-47,398
| -49% | -$837K |
|
3678
Aquestive Therapeutics
AQST
$463M
| $871K | ﹤0.01% |
219,642
-135,214
| -38% | -$540K |
|
3679
Moleculin Biotech
MBRX
$2.83M
| $871K | ﹤0.01% |
634
+168
| +36% | +$229K |
|
|
UBFO
3680
DELISTED
United Security Bancshares
UBFO
| $871K | ﹤0.01% |
106,632
-80,575
| -43% | -$654K |
|
3681
Milestone Scientific
MLSS
$35.3M
| $870K | ﹤0.01% |
355,202
-339,189
| -49% | -$823K |
|
3682
Lloyds Banking Group
LYG
$89.5B
| $869K | ﹤0.01% |
340,996
+16,083
| +5% | +$41.3K |
|
|
FNCB
3683
DELISTED
FNCB Bancorp Inc. Common Stock
FNCB
| $869K | ﹤0.01% |
119,629
-111,936
| -48% | -$811K |
|
|
CFRX
3684
DELISTED
ContraFect Corporation
CFRX
| $867K | ﹤0.01% |
2,465
-2,070
| -46% | -$678K |
|
3685
Smart Sand
SND
$185M
| $866K | ﹤0.01% |
260,113
+21,580
| +9% | +$56.5K |
|
3686
VolitionRx Ltd
VNRX
$8.65M
| $862K | ﹤0.01% |
13,105
-11,585
| -47% | -$784K |
|
|
GPUS
3687
Hyperscale Data Inc
GPUS
$55.4M
| $849K | ﹤0.01% |
2
+1
| +100% | +$430K |
|
|
TONX
3688
TON Strategy Co
TONX
$168M
| $848K | ﹤0.01% |
52
+8
| +18% | +$77.7K |
|
3689
NACCO Industries
NC
$357M
| $845K | ﹤0.01% |
32,474
-24,450
| -43% | -$608K |
|
3690
Village Farms International
VFF
$234M
| $845K | ﹤0.01% |
79,064
+36,259
| +85% | +$382K |
|
|
BIOL
3691
DELISTED
Biolase, Inc.
BIOL
| $844K | ﹤0.01% |
484
+7
| +1% | +$13K |
|
|
CORR
3692
DELISTED
CorEnergy Infrastructure Trust, Inc.
CORR
| $843K | ﹤0.01% |
127,405
-128,212
| -50% | -$820K |
|
3693
ORIX
IX
$44B
| $842K | ﹤0.01% |
49,775
+425
| +0.9% | +$7.25K |
|
|
HIL
3694
DELISTED
Hill International, Inc. Common Stock
HIL
| $842K | ﹤0.01% |
338,381
+22,637
| +7% | +$60.4K |
|
|
ZSAN
3695
DELISTED
Zosano Pharma Corporation
ZSAN
| $842K | ﹤0.01% |
25,347
+2,151
| +9% | +$69.3K |
|
3696
Koss Corp
KOSS
$34.8M
| $838K | ﹤0.01% |
36,094
+6,359
| +21% | +$136K |
|
3697
Fuel Tech
FTEK
$43.9M
| $836K | ﹤0.01% |
356,098
+195,843
| +122% | +$455K |
|
3698
Saga Communications
SGA
$57M
| $834K | ﹤0.01% |
38,551
-15,252
| -28% | -$336K |
|
3699
Anixa Biosciences
ANIX
$116M
| $829K | ﹤0.01% |
213,804
+44,846
| +27% | +$191K |
|
3700
Beyond Air
XAIR
$3.8M
| $829K | ﹤0.01% |
320
-289
| -47% | -$632K |
|
Similar funds
Geode Capital Management's Q2 2021 Portfolio in Review
As of Q2 2021, Geode Capital Management held 4,790 positions worth $726B, up 11% from $654B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Geode Capital Management's Q2 2021 filing shows 331 new, 3,384 increased, 720 reduced and 74 closed positions. Its largest new stake was Organon & Co: 5,070,121 shares worth $153M. The largest sale was Sherwin-Williams, an estimated $1.88B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q2 2021 buy was Organon & Co: 5,070,121 shares worth $153M.
- Geode Capital Management added most to Microsoft in Q2 2021, an estimated $786M increase.
- Geode Capital Management's biggest Q2 2021 reduction was Sherwin-Williams, cutting an estimated $1.88B.
- Geode Capital Management fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $274M.
- Geode Capital Management's ten largest holdings make up 22% of its $726B portfolio in Q2 2021.
- Geode Capital Management opened 331 new positions and closed 74 in Q2 2021.
- Geode Capital Management's portfolio value rose 11% quarter-over-quarter to $726B.
Based on Geode Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.